Abstract:Objective: Human-antigen R (HuR) is an RNA-binding protein, which regulates the expression of several oncogenes and tumor suppressor genes through post-transcriptional mechanisms. But the role of HuR in breast cancer remains controversial. The aim of this study was to verify the association between cytoplasmic HuR level and prognosis of breast cancer patients. Methods: Data mining from the Human Protein Atlas (HPA) and Kaplan-Meier Plotter (KMP) databases was performed. Then, 394 patients with stage I-III primary breast cancer were enrolled between January 2005 and December 2016. We investigated the association between cytoplasmic HuR level and clinicopathological characteristics or survival of these patients. Immunohistochemical analysis was performed to determine HuR expression level. SPSS 21.0 statistical software was used for analysis. Results: In the HPA and KMP datasets, HuR protein and mRNA expression level were not significantly associated with overall survival of all breast cancer patients enrolled. Results from our 394 patients indicated that higher expression level of cytoplasmic HuR was associated with larger tumor size, lymph node positive, ER negative and triple-negative subtype. For all patients enrolled, the results indicated that compared with HuR negative patients, the DFS (disease-free survival) of HuR 1+ was longer (60.5% vs 78.8, P=0.053, HR=0.616, 95% CI: 0.378-1.005), the P value was borderline. In the triple-negative breast cancer (TNBC) subgroup, HuR positive patients had significantly longer DFS than HuR negative patients (65.5% vs 30.8%, P=0.001, HR=0.345, 95% CI: 0.180-0.658). In the HR+HER2- subgroup, HuR low (0 similar to 1+) patients had significantly longer OS than HuR high (2+similar to 3+) patients (97.0% vs 89.5%, P=0.033, HR=2.482, 95% CI: 1.074-5.736). Conclusion: In conclusion, our results revealed that higher expression level of HuR was related to aggressive biological character-istics which supported the findings from previous researches. In the HR+HER2- subgroup, lower HuR expression level patients had better survival time, while in the TNBC subgroup we got the opposite results. Our work indicated that HuR might play different roles in different breast cancer subtypes.

The RNA-Binding Protein HuR in Digestive System Tumors

The RNA-binding protein HuR in human cancer: A friend or foe?

Targeting the RNA-binding protein HuR in cancer.

HuR Affects the Radiosensitivity of Esophageal Cancer by Regulating the EMT-Related Protein Snail

Multiple Functions of the RNA-Binding Protein HuR in Cancer Progression, Treatment Responses and Prognosis

Multiple Functions of HuR in Urinary Tumors

Human antigen R and drug resistance in tumors

The Role of RNA-Binding Protein HuR in Lung Cancer by RNA Sequencing Analysis

HuR, a Key Post-Transcriptional Regulator, and Its Implication in Progression of Breast Cancer.

Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells

An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells

The Prognostic Role of HuR Varies Between Different Subtypes of Breast Cancer Patients: Data Mining and Retrospective Analysis.

The expression of human antigen R and vascular endothelial growth factor-C and their significance in non-small cell lung cancer]

HuR Protein in Hepatocellular Carcinoma: Implications in Development, Prognosis and Treatment

The Expression of RNA-Binding Protein HuR in Non-Small Cell Lung Cancer Correlates with Vascular Endothelial Growth Factor-C Expression and Lymph Node Metastasis

Small Molecules Targeting the RNA-Binding Protein HuR Inhibit Tumor Growth in Xenografts

The RNA-binding Protein HuR Regulates Intestinal Epithelial Restitution by Modulating Caveolin-1 Gene Expression

The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer

RAB5C, a New Mrna Binding Target of HuR, Regulates Breast Cancer Cell Proliferation

Oncogenic Circticrr Suppresses Autophagy Via Binding to HuR Protein and Stabilizing GLUD1 Mrna in Cervical Cancer

Circ-HuR Suppresses HuR Expression and Gastric Cancer Progression by Inhibiting CNBP Transactivation.